Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

93 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomes.
Krajewski W, Moschini M, Chorbińska J, Nowak Ł, Poletajew S, Tukiendorf A, Afferi L, Teoh JY, Muilwijk T, Joniau S, Tafuri A, Antonelli A, Cianflone F, Mari A, Di Trapani E, Hendricksen K, Alvarez-Maestro M, Rodríguez-Serrano A, Simone G, Zamboni S, Simeone C, Marconi MC, Mastroianni R, Ploussard G, Laukhtina E, Tully K, Kołodziej A, Krajewska J, Piszczek R, Xylinas E, Zdrojowy R; European Association of Urology—Young Academic Urologists (EAU-YAU): Urothelial carcinoma working group. Krajewski W, et al. Among authors: poletajew s. World J Urol. 2021 Jul;39(7):2545-2552. doi: 10.1007/s00345-020-03522-3. Epub 2020 Nov 23. World J Urol. 2021. PMID: 33230571 Free PMC article.
Availability and Patterns of Intravesical BCG Instillations.
Poletajew SA, Majek A, Magusiak P, Ledzikowska K, Dybowski B, Radziszewski P. Poletajew SA, et al. Urol J. 2017 Nov 4;14(6):5068-5070. doi: 10.22037/uj.v14i6.3781. Urol J. 2017. PMID: 29101762 Free article.
Re: Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non-muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial.
Radziszewski P, Poletajew S. Radziszewski P, et al. Among authors: poletajew s. Eur Urol. 2019 May;75(5):879-880. doi: 10.1016/j.eururo.2019.01.030. Epub 2019 Feb 1. Eur Urol. 2019. PMID: 30712968 No abstract available.
93 results